January 5, 2017January 9, 2017

Sunovion Secures US Marketing Rights for 3 Approved COPD Treatments

COPD, News

Sunovion Pharmaceuticals announced its entry into a license agreement with Novartis for exclusive U.S. commercialization rights to three U.S. Food and Drug Administration (FDA)- approved and long-term treatments for airflow obstruction in people with chronic ... Read more

October 30, 2015November 9, 2015

FDA Approves Novartis’ Utibron Neohaler Dual Bronchodilator for COPD

COPD, News

Novartis announced that the FDA recently approved the dual combined bronchodilator Utibron™ Neohaler® (indacaterol/glycopyrrolate), an inhalation powder for long-term maintenance therapy of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including ... Read more